Press Releases
Newsletters
AGT Newsletter Volume 9
VOLUME 9 May 2020 Newsletter FDA Progress The Path to the Clinic For the HIV Cure This month, AGT saw tremendous progress with the FDA. FDA time and attention to our project has seemed to increase while agency...
Happy New Year! AGT Newsletter – 2020 Edition
A STELLAR 2019 Has Positioned AGT For A SPECTACULAR 2020. I wanted to take a moment to sum up a great year of progress and success at AGT and to talk about potential milestones and significant inflection points ...
AGT Newsletter Volume 8
Featured Stories AGT’s HIV cure program is nearing a major milestone: Investigational New Drug (IND) submission. The IND is the key document that reports the safety data the FDA requires prior to a human trial...
AGT Newsletter Volume 7
Newsletter Vol. 7 In wrapping up the year, AGT was proud to be featured as a State of Maryland “Success Story” for its growth in Maryland and achievements in the gene and cell therapy industry. Watch The Vid...
Latest Videos
Published Articles
Latest From The Blog
Join Our Newsletter
Subscribe to our newsletter to keep up to date with all the latest news about AGT!
Latest AGT Tweets
On the cusp of a cure? @jeffreygalvin talks with @Bethesda_Mag about the progression happening within AGT, his day-to-day approach, and why looking forward to a brighter future is possible.
https://t.co/Xzg7fYVGau
Check out @BioBuzzMaryland's 5 Questions with @jeffreygalvin, Founder and CEO of American Gene ⬇️
➡️ https://t.co/8aCDMa4jAN
#leadership #biotech
At AGT, our unique cell and gene therapy technology is being used to pursue a cure for HIV. This method can also be used to cure other diseases like PKU and Liver Cancer. #HIVCure #LiverCancer #PKU
https://t.co/kpCXUZGQXz
